88 related articles for article (PubMed ID: 8377126)
1. Comparison of tebufelone distribution in rat blood plasma and inflamed and noninflamed tissues following peroral and intravenous administration.
Doyle MJ; Eichhold TH; Loomans ME; Farmer RW; Kelm GR
J Pharm Sci; 1993 Aug; 82(8):847-50. PubMed ID: 8377126
[TBL] [Abstract][Full Text] [Related]
2. Absorption, bioavailability, and pharmacokinetics of tebufelone in the rat.
Sietsema WK; Kelm GR; Deibel RM; Doyle MJ; Loomans ME; Smyth RE; Kinnett GO; Eichhold TH; Farmer RW
J Pharm Sci; 1993 Jun; 82(6):610-2. PubMed ID: 8331535
[TBL] [Abstract][Full Text] [Related]
3. Determination of tebufelone, a new anti-inflammatory drug, in plasma and tissue using capillary gas chromatography/stable isotope dilution mass spectrometry.
Eichhold TH; Doyle MJ
Biomed Environ Mass Spectrom; 1990 Apr; 19(4):230-4. PubMed ID: 2340361
[TBL] [Abstract][Full Text] [Related]
4. Interspecies scaling of tebufelone pharmacokinetic data and application to preclinical toxicology.
Cruze CA; Kelm GR; Meredith MP
Pharm Res; 1995 Jun; 12(6):895-901. PubMed ID: 7667197
[TBL] [Abstract][Full Text] [Related]
5. Automated gas chromatography/tandem mass spectrometry assay for tebufelone and a 13C,(18)O-labeled analog in plasma: applicabilityto absolute bioavailability determination.
Dobson RL; Kelm GR; Neal DM
Biol Mass Spectrom; 1994 Feb; 23(2):75-81. PubMed ID: 8123692
[TBL] [Abstract][Full Text] [Related]
6. Automated gas chromatography/tandem mass spectrometry with on-line chemical derivatization for the determination of tebufelone and two metabolites in human plasma.
Dobson RL; Dirr MK; Merkt BL
J Mass Spectrom; 1997 Dec; 32(12):1290-8. PubMed ID: 9423282
[TBL] [Abstract][Full Text] [Related]
7. Correlation of anti-inflammatory activity with peak tissue rather than peak plasma levels of BF389.
Bendele AM; Ruterbories KJ; Spaethe SM; Benslay DN; Lindstrom TD; Lee SJ; Naismith RW
J Pharmacol Exp Ther; 1992 Mar; 260(3):1194-8. PubMed ID: 1545387
[TBL] [Abstract][Full Text] [Related]
8. Antipyretic activity of tebufelone (NE-11740) in man.
Powell JH; Meredith MP; Vargas R; McMahon FG; Jain AK
Agents Actions Suppl; 1991; 32():45-9. PubMed ID: 2069096
[TBL] [Abstract][Full Text] [Related]
9. Preferential uptake of the non steroid anti-inflammatory drug diclofenac into inflamed tissues after a single oral dose in rats.
Schweitzer A; Hasler-Nguyen N; Zijlstra J
BMC Pharmacol; 2009 Mar; 9():5. PubMed ID: 19291310
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a benchtop ion trap gas chromatographic-tandem mass spectrometric instrument for the analysis of a model drug, tebufelone, in plasma using a stable-isotope internal standard.
Wehmeyer KR; Knight PM; Parry RC
J Chromatogr B Biomed Appl; 1996 Feb; 676(1):53-9. PubMed ID: 8852044
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the effects of tebufelone on hepatic cytochromes P450 in the beagle dog.
Smith BJ; Zupan LA; Hu JK; Diters RW; Gibson GW; Norton JN
Drug Metab Dispos; 1996 May; 24(5):523-8. PubMed ID: 8723731
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of etanercept to tissues and sites of inflammation in arthritic rats.
Chen X; DuBois DC; Almon RR; Jusko WJ
Drug Metab Dispos; 2015 Jun; 43(6):898-907. PubMed ID: 25834031
[TBL] [Abstract][Full Text] [Related]
13. Enhanced in vivo performance of liposomal indomethacin derived from effervescent granule based proliposomes.
Katare OP; Vyas SP; Dixit VK
J Microencapsul; 1995; 12(5):487-93. PubMed ID: 8544092
[TBL] [Abstract][Full Text] [Related]
14. Analysis of a novel antiinflammatory agent, 1-(7-tert.-butyl-2,3-dihydro-3,3-dimethylbenzo[b]furan-5-yl)-4- cyclopylbutan-1-one (PGV-20229), in plasma matrices by stable-isotope-dilution gas chromatography-mass spectrometry.
Knight PM; Scherz MW; Cruze CA; Wehmeyer KR
J Chromatogr B Biomed Sci Appl; 1997 Oct; 700(1-2):111-8. PubMed ID: 9390720
[TBL] [Abstract][Full Text] [Related]
15. Carprofen pharmacokinetics in plasma and in control and inflamed canine tissue fluid using in vivo ultrafiltration.
Messenger KM; Wofford JA; Papich MG
J Vet Pharmacol Ther; 2016 Feb; 39(1):32-9. PubMed ID: 25958925
[TBL] [Abstract][Full Text] [Related]
16. Long-term performance of a gas chromatography/tandem mass spectrometry assay for tebufelone in plasma.
Dobson RL; Neal DM; DeMark BR; Ward SR
Anal Chem; 1990 Sep; 62(17):1819-24. PubMed ID: 2240571
[TBL] [Abstract][Full Text] [Related]
17. Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw.
Costa B; Colleoni M; Conti S; Parolaro D; Franke C; Trovato AE; Giagnoni G
Naunyn Schmiedebergs Arch Pharmacol; 2004 Mar; 369(3):294-9. PubMed ID: 14963641
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of chemokine expression in rat inflamed paws by systemic use of the antihyperalgesic oxidized ATP.
Fulgenzi A; Dell'Antonio G; Foglieni C; Dal Cin E; Ticozzi P; Franzone JS; Ferrero ME
BMC Immunol; 2005 Jul; 6():18. PubMed ID: 16042776
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of carrageenan-induced edema by indomethacin or sodium salicylate does not prevent the increase of nerve growth factor in the rat hind paw.
Amann R; Schuligoi R
Neurosci Lett; 2000 Jan; 278(3):173-6. PubMed ID: 10653021
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of ethylene glycol. II. Tissue distribution, dose-dependent elimination, and identification of urinary metabolites following single intravenous, peroral or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Dietz FK; Ballantyne B
Xenobiotica; 1996 Nov; 26(11):1195-220. PubMed ID: 8948094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
